SNSE Sensei Bio: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Sensei Biotherapeutics Inc (SNSE)

Is the investment attractiveness of Sensei Biotherapeutics (SNSE), which develops advanced vaccines to train the immune system to fight tumors, compelling? The EV/Sales trend on this GURU.Markets platform chart, where the value is fixed at 0.00, provides the answer. The business is highly resilient to crises during the R&D stage, as saving lives remains a priority. The company's growth relies on the success of clinical trials and the commercialization of its products.

Nilai perusahaan marang pendapatan: Sensei Bio (SNSE) kanggo 23.11.2025 - 16.06.2026

Sensei Bio - rincian analitis lan metrik utama (SNSE)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Sensei Biotherapeutics Inc SNSE
Sampel barang Sensei Biotherapeutics Inc

The innovative ImmunoPhage platform provides Sensei Biotherapeutics (SNSE) with a competitive advantage in developing targeted vaccines against resistant tumors. The company's enterprise value-to-revenue metric quantifies this potential by comparing the total business value net of debt against sales volume, allowing investors to assess real capitalization per unit of revenue and determine the asset's true trend on this chart.

Analisis pesaing Sensei Biotherapeutics

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|Nilai bisnis marang pendapatan LPTX|INTS - Rasio nilai perusahaan marang pendapatan|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP